196 related articles for article (PubMed ID: 12469688)
1. Quetiapine augmentation of sertraline in obsessive-compulsive disorder.
Francobandiera G
J Clin Psychiatry; 2002 Nov; 63(11):1046-7. PubMed ID: 12469688
[No Abstract] [Full Text] [Related]
2. Quetiapine plus SSRI in treatment-resistant depression: possible mechanisms.
Devarajan S; Ali J; Dursun SM
Psychopharmacology (Berl); 2006 Apr; 185(3):402-3. PubMed ID: 16538471
[No Abstract] [Full Text] [Related]
3. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder.
Mohr N; Vythilingum B; Emsley RA; Stein DJ
Int Clin Psychopharmacol; 2002 Jan; 17(1):37-40. PubMed ID: 11800505
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up case series.
Dell'Osso B; Mundo E; Altamura AC
CNS Spectr; 2006 Nov; 11(11):879-83; quiz 885. PubMed ID: 17075559
[TBL] [Abstract][Full Text] [Related]
5. Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial.
Diniz JB; Shavitt RG; Pereira CA; Hounie AG; Pimentel I; Koran LM; Dainesi SM; Miguel EC
J Psychopharmacol; 2010 Mar; 24(3):297-307. PubMed ID: 19164490
[TBL] [Abstract][Full Text] [Related]
6. A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Matsunaga H; Nagata T; Hayashida K; Ohya K; Kiriike N; Stein DJ
J Clin Psychiatry; 2009 Jun; 70(6):863-8. PubMed ID: 19422759
[TBL] [Abstract][Full Text] [Related]
7. Urinary retention with sertraline, haloperidol, and clonazepam combination.
Benazzi F
Can J Psychiatry; 1998 Dec; 43(10):1051-2. PubMed ID: 9868574
[No Abstract] [Full Text] [Related]
8. A double-blind, randomized, controlled trial of fluoxetine plus quetiapine or clomipramine versus fluoxetine plus placebo for obsessive-compulsive disorder.
Diniz JB; Shavitt RG; Fossaluza V; Koran L; Pereira CA; Miguel EC
J Clin Psychopharmacol; 2011 Dec; 31(6):763-8. PubMed ID: 22020357
[TBL] [Abstract][Full Text] [Related]
9. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.
Storch EA; Lehmkuhl H; Geffken GR; Touchton A; Murphy TK
Depress Anxiety; 2008; 25(2):172-4. PubMed ID: 17340610
[TBL] [Abstract][Full Text] [Related]
11. Quetiapine addition to serotonin reuptake inhibitors in patients with severe obsessive-compulsive disorder: a double-blind, randomized, placebo-controlled study.
Kordon A; Wahl K; Koch N; Zurowski B; Anlauf M; Vielhaber K; Kahl KG; Broocks A; Voderholzer U; Hohagen F
J Clin Psychopharmacol; 2008 Oct; 28(5):550-4. PubMed ID: 18794652
[TBL] [Abstract][Full Text] [Related]
12. Quetiapine addition in obsessive-compulsive disorder: is treatment outcome affected by type and dose of serotonin reuptake inhibitors?
Denys D; Fineberg N; Carey PD; Stein DJ
Biol Psychiatry; 2007 Feb; 61(3):412-4. PubMed ID: 17241831
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania.
Matur Z; Uçok A
Isr J Psychiatry Relat Sci; 2003; 40(2):150-2. PubMed ID: 14509206
[TBL] [Abstract][Full Text] [Related]
14. Sertraline and obsessive compulsive disorder: new indication. Limited assessment.
Prescrire Int; 2000 Aug; 9(48):112-3. PubMed ID: 11067720
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study.
McIntyre A; Gendron A; McIntyre A
Depress Anxiety; 2007; 24(7):487-94. PubMed ID: 17177199
[TBL] [Abstract][Full Text] [Related]
16. Intermittent Electric Shock-Like Sensations Associated With Sertraline Use for Treatment of Obsessive-Compulsive Disorder.
Viani I; Meyer F
J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):101-103. PubMed ID: 34928566
[No Abstract] [Full Text] [Related]
17. Quetiapine augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive-compulsive disorder: is response to treatment predictable?
Carey PD; Lochner C; Kidd M; Van Ameringen M; Stein DJ; Denys D
Int Clin Psychopharmacol; 2012 Nov; 27(6):321-5. PubMed ID: 22859064
[TBL] [Abstract][Full Text] [Related]
18. Priapism associated with sertraline.
Bonnot O; Warot D; Cohen D
J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):790-1. PubMed ID: 17581442
[No Abstract] [Full Text] [Related]
19. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.
Denys D; de Geus F; van Megen HJ; Westenberg HG
J Clin Psychiatry; 2004 Aug; 65(8):1040-8. PubMed ID: 15323587
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.
Sarkar R; Klein J; Krüger S
Psychopharmacology (Berl); 2008 May; 197(4):687-8. PubMed ID: 18264798
[No Abstract] [Full Text] [Related]
[Next] [New Search]
